News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Catabasis Pharmaceuticals, Inc. Announces Issuance Of Three New US Patents For CAT-1000 Series



6/11/2014 8:24:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals Inc. today announced that the United States Patent and Trademark Office issued three new patents titled “Fatty acid acetylated salicylates and their uses”, incorporating composition of matter and method of use claims related to the CAT-1000 series of molecules for the treatment of inflammatory disorders. The newly-issued patents are: US 8,729,293, US 8,735,378 and US 8,735,379. The method of use claims in these patents cover multiple inflammatory disease indications, including Duchenne muscular dystrophy (DMD).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES